about
Thy-1 is expressed in hepatic myofibroblasts and not oval cells in stem cell-mediated liver regeneration.Richter's and prolymphocytic transformation of chronic lymphocytic leukemia are associated with high mRNA expression of activation-induced cytidine deaminase and aberrant somatic hypermutation.Functional analysis of a breast cancer-associated FGFR2 single nucleotide polymorphism using zinc finger mediated genome editing.EBNA3B-deficient EBV promotes B cell lymphomagenesis in humanized mice and is found in human tumors.Germ-line GATA2 p.THR354MET mutation in familial myelodysplastic syndrome with acquired monosomy 7 and ASXL1 mutation demonstrating rapid onset and poor survival.Enhancer of zeste homologue 2 (EZH2) is a reliable immunohistochemical marker to differentiate malignant and benign hepatic tumors.P110α-mediated constitutive PI3K signaling limits the efficacy of p110δ-selective inhibition in mantle cell lymphoma, particularly with multiple relapseEZH2 mutations are frequent and represent an early event in follicular lymphoma.Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma.Functional studies of chronic lymphocytic leukemia B cells expressing β2-integrin type complement receptors CR3 and CR4.Catalog of genetic progression of human cancers: non-Hodgkin lymphoma.Increased Lipocalin 2 level may have important role in thrombotic events in patients with polycythemia vera and essential thrombocythemia.Impact of the reactive microenvironment on the bone marrow involvement of follicular lymphoma.Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma.Highly variable clinical manifestations in a large family with a novel GATA2 mutation.Aberrant somatic hypermutation and expression of activation-induced cytidine deaminase mRNA in mediastinal large B-cell lymphoma.Discrepancy Between Low Levels of mTOR Activity and High Levels of P-S6 in Primary Central Nervous System Lymphoma May Be Explained by PAS Domain-Containing Serine/Threonine-Protein Kinase-Mediated Phosphorylation.Familial Acute Myeloid Leukemia and Myelodysplasia in Hungary.[State of the art molecular diagnostics and therapy of chronic lymphocytic leukaemia in the era of new targeted therapies].Quantitative assessment of JAK2 V617F and CALR mutations in Philadelphia negative myeloproliferative neoplasms.Recurrent somatic JAK-STAT pathway variants within a RUNX1-mutated pedigree.[TP53 mutation analysis in chronic lymphocytic leukaemia].Altered microRNA expression in folliculotropic and transformed mycosis fungoides.Low CD23 expression correlates with high CD38 expression and the presence of trisomy 12 in CLL.[Chronic myelogenous leukemia: diagnosis and treatment].[Clinical and genetic background of familial myelodysplasia and acute myeloid leukemia].Structural analysis of oval-cell-mediated liver regeneration in rats.Treatment of refractory hairy cell leukemia with a BRAF-inhibitor: lessons to be learnt.EZH2 Y641 mutations in follicular lymphoma.Elevated expression of Cu, Zn-SOD and Mn-SOD mRNA in inflamed dental pulp tissue.Clonal selection in the bone marrow involvement of follicular lymphoma.[Change in paradigm in the treatment of pediatric acquired bone marrow failure syndromes in Hungary]Spatial clonal evolution leading to ibrutinib resistance and disease progression in chronic lymphocytic leukemiaPrognostic significance and detection of the internal tandem duplication of the FLT3 gene in acute myeloid leukemiaDNA and RNA isolated from tissues processed by microwave-accelerated apparatus MFX-800-3 are suitable for subsequent PCR and Q-RT-PCR amplificationMyelodysplastic syndrome: 2011 and beyondROR1 expression is not a unique marker of CLL[Multiplex ligation-dependent probe amplification in oncohematological diagnostics and research]GATA2 monoallelic expression underlies reduced penetrance in inherited GATA2-mutated MDS/AMLConcomitant 1p36 deletion and TNFRSF14 mutations in primary cutaneous follicle center lymphoma frequently expressing high levels of EZH2 protein
P50
Q30480301-20F335B1-40BF-478C-88AF-B898C9E1C70EQ34502653-486C046F-55AC-4612-8BCC-5BCA100E5F3AQ35050363-2DBB6AD4-78A1-4FAB-8A17-8D67DA2E54ECQ35858022-029EDCC7-7C6E-4035-897D-BE920E3D31C6Q36006394-CB71C0AE-4329-4D5F-B43A-E914A836927DQ36217858-AAB0FBA1-43F8-4EBC-A017-B806CA264BC2Q36709839-83E2339B-F25F-4672-9AB0-33B2B5478677Q37272035-EE7C8178-8D11-4585-8A3A-796C22851263Q37533656-F8A30DAE-0496-4BDA-99D3-E92BA6C2F442Q38746794-5F389B69-F80B-4F3D-9568-6226E3BA563EQ38766227-5379BCFF-CC91-41C4-A07D-FB34362AD690Q39781329-E5257770-B0D5-4E57-A2FC-7C8D7440C4B8Q40025028-741F5996-D3E0-422B-A9E9-5470A38D2CA0Q40183645-CB3B05ED-179B-4670-9A35-8C0E058812ABQ43989975-43E7C75F-C769-44E0-83DD-317CBB4553F2Q46447362-B73E8047-D8D7-4BFF-AB8A-9CF32B21ED7DQ47844692-9032ED3F-0517-40B7-82BE-E04D18BB6AA7Q48345892-EDA4DCE7-D541-4429-8744-07A42EA3E66DQ50100492-D1578195-7DC9-435D-B67A-EA1966AC4528Q50117609-AFB589CF-E0FC-4BA8-BB3C-420165932688Q50996855-55357A6A-38F0-4A49-A61C-FB621A38EA33Q52912459-9D199104-25FF-470C-8E48-C357E5E626D6Q53223479-65894CA9-A062-4AB0-B140-FB6AB966AA96Q53450213-50D08B42-18BD-4425-AB17-1C50C794DFB4Q53770195-2ADF2DD0-9C27-4E20-B409-6E0F1BF2BE6CQ54215067-C00789F0-9B36-4FAE-A745-D84957DCA4A5Q54319121-932A49ED-36DE-4CB2-B86E-BA349A0375F2Q54355646-FB11C30C-7864-4B7D-9685-FA65E9A2BA6FQ54392744-817B193E-9DCF-4619-B3EF-B8AFAF946FEFQ54561860-1B682797-15C0-4BE2-9077-2D75655BC07CQ54657499-F20E8E05-1599-4D0A-B2A2-67BA1B583498Q58599388-D7845BB7-F06F-44EC-AA41-A8E7252C8E02Q60922686-A188C765-DFF6-45DA-915D-3020BFE7CBBAQ80059205-CCD2C028-0315-4DA4-8DD4-3909E290DF61Q80559056-EBD47E4C-ED3C-4460-B97A-292107126EDEQ83224268-B616BA66-F859-4E02-AB78-C23511B91F42Q84513968-B892014F-7B66-47DE-B399-68B8768C0AB1Q88309182-AAEBA339-DD38-4FDA-82F5-AC5A3B3C5062Q88636714-40DEEE45-34F4-48A2-A087-B93B34E6075DQ88955968-7E57F463-0979-4F20-8AF9-9B7F474BFF8E
P50
description
researcher, ORCID id # 0000-0002-0729-692X
@en
wetenschapper
@nl
name
Csaba Bödör
@ast
Csaba Bödör
@en
Csaba Bödör
@nl
type
label
Csaba Bödör
@ast
Csaba Bödör
@en
Csaba Bödör
@nl
prefLabel
Csaba Bödör
@ast
Csaba Bödör
@en
Csaba Bödör
@nl
P106
P21
P31
P496
0000-0002-0729-692X